The.ei is conducting and supporting research that seeks better ways to detect, treat, and prevent vision loss in people with diabetes. The macula is important for the sharp, straight-ahead vision that is used for reading, recognizing faces, and driving. Treatment involves making 1,000 to 2,000 tiny laser burns in areas of the retina away from the macula. Exciting research for diabetes and diabetic retinopathy is ongoing. Diabetic and hypertensive retinopathy are diagnosed in much the same way. A condition known as diabetic macular oedema occurs when blood leaks into the centre of the retina, known as the macula, the part of the eye where sharp, straight-ahead vision occurs. The retina detects light and converts it to signals sent through the optic nerve to the brain. Typically, both eyes are affected. The um Kellogg Eye enter does not operate, associate, endorse or take responsibility for any of the content on the following web sites. Controlling blood sugar levels in diabetes is critical in delaying the onset of diabetic retinopathy. Proliferative retinopathy occurs as background retinopathy develops and large areas of the retina are deprived of a proper blood supply because of blocked and damaged blood vessels. Medicines that are injected into the eyeball may help prevent abnormal blood vessels from growing. no dataIn later stages of retinopathy, serious complications can result, including retinal detachment and blindness .
The good news is that Eylea continues to post solid sales numbers. The bad news is that the drug’s sales growth is slowing somewhat. Regeneron’s future depends heavily on Praluent. While sales for the cholesterol drug are picking up momentum, Praluent hasn’t been a rousing success yet. The problem is that payers have been reluctant to open their purse strings. http://dclakers.com/advisingeyesurgeon/2016/12/05/a-closer-look-at-strategies-of-cataracts/Regeneron and partner Sanofi ( NYSE:SNY ) expect that to change once the results from a major cardiovascular outcomes study are available. Some had hoped that studywould wrap up sooner than planned if an interim analysis found overwhelming positive results. Those hopes weredashed, however, when Regeneron and Sanofi announced on Nov. 17 that the independent data monitoring committee recommended the study continue into next year. Final results probably won’t be available until early 2018. Praluent should eventually be a big winner for Regeneron, though.
For the original version including any supplementary images or video, visit http://www.fool.com/investing/2016/11/18/better-buy-regeneron-pharmaceuticals-inc-vs-novart.aspx?source=iedfolrf0000001
When the retina has already detached or a lot of blood has leaked into the eye, photo coagulation is no longer useful. Non-proliferative Diabetic Retinopathy is characterized by leakage from small retinal blood vessels capillaries. Eventually, blood can leak into the retina, causing further damage. In addition to a vitrectomy, retinal repair may be necessary if scar tissue has detached the retina from the back of your eye. However, they are weak and often burst, causing bleeding in the eye. Fluid can leak into the part of the eye where focusing occurs, the macula. The vitreous is the clear gel between the lens and the retina. Additional exams during pregnancy may be needed. Hypertensive retinopathy — Avoid high blood pressure by: Taking blood pressure medications as directed Central serous retinopathy — The possible causes of this disease are not understood. However, patients who started the trial with 20/50 or worse vision had greater improvements in vision with Eylea.